Ketamine’s antidepressive effects require activation of opioid receptors in the brain, a new Stanford study shows. The surprising finding may alter how new antidepressants are developed and administered in order to mitigate the risk of opioid dependence.
Increasing the availability of naloxone, cutting opioid prescriptions by 25 percent and expanding drug-treatment programs could reduce opioid-related deaths by 6,000 over 10 years, Stanford researchers estimate.
By combining genome-sequence information and health records, Stanford scientists have developed a new algorithm that can predict the risk of abdominal aortic aneurysm, and potentially could be used for any number of diseases.
The summer issue of Stanford Medicine highlights research and programs that reflect a shared vision for the future of the School of Medicine, Stanford Health Care and Lucile Packard Children’s Hospital Stanford.
Inside Stanford Medicineis a twice-monthly newspaper that reports on the accomplishments and activities of the faculty, staff and students in the Stanford Medicine community. To suggest a story or to get more information, contact editor John Sanford at (650) 723-8309 or email@example.com.
You're receiving this newsletter because you registered with us.
Not interested anymore? Unsubscribe here.